2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Colchicine: new trials by email Literature Review of Colchicine trials Research Report on Colchicine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis Colchicine 0.5 mg orally once daily for 12 months., SoC therapy - Colchicine, Coronary Atherosclerosis Management | Phase 4 | Recruiting | Shenyang Northern Hospital | 120 | 2026-06-08 | 2026-10-01 |
| Colchicine's Effect on Inflammatory Markers Colchicine (Colcrys®), Placebo - Colchicine, Inflammation in Cardiac Surgery | Phase 4 | Recruiting | Ayesha Ather | 24 | 2026-01-16 | 2026-06-25 |
Colchicine (2)
Ayesha Ather (1) · Shenyang Northern Hospital (1)
China (1) · United States (1)
Sibu Saha, MD (1) · Yaling Han, MD, PhD (1)